Key result
Higher day 3 CD14+CD16- monocytes linked to worse myocardial salvage and 6-month LVEF recovery.
Why the study?
Distinct monocyte subsets in human peripheral blood may contribute differently to myocardial salvage in patients with acute myocardial infarction.
Population
36 patients with primary acute myocardial infarction
Comparison
CD14(+)CD16(-) monocytes vs CD14(+)CD16(+) monocytes
Design
Observational study with serial peripheral blood sampling and cardiovascular magnetic resonance imaging
Follow-up
6 months
Authors
Loading...
Observational study reveals elevated CD14+CD16- monocytes hinder myocardial salvage in acute myocardial infarction patients, suggesting targetable pathways for ischemic recovery.
Observational (n=36)
Tsujioka et al. (2009) conducted an observational in Primary acute myocardial infarction (n=36). CD14(+)CD16(-) and CD14(+)CD16(+) monocyte subsets was evaluated on Extent of myocardial salvage at 7 days and recovery of left ventricular ejection fraction at 6 months. Peak levels of CD14(+)CD16(-) monocytes on day 3 were significantly negatively associated with the extent of myocardial salvage at 7 days and recovery of left ventricular function at 6 months.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: